BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ruiz-Miyazawa KW, Staurengo-Ferrari L, Pinho-Ribeiro FA, Fattori V, Zaninelli TH, Badaro-Garcia S, Borghi SM, Andrade KC, Clemente-Napimoga JT, Alves-Filho JC, Cunha TM, Fraceto LF, Cunha FQ, Napimoga MH, Casagrande R, Verri WA Jr. 15d-PGJ2-loaded nanocapsules ameliorate experimental gout arthritis by reducing pain and inflammation in a PPAR-gamma-sensitive manner in mice. Sci Rep 2018;8:13979. [PMID: 30228306 DOI: 10.1038/s41598-018-32334-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
Number Citing Articles
1 Uemura L, Baggio Simeoni R, Bispo Machado Júnior PA, Gavazzoni Blume G, Kremer Gamba L, Sgarbossa Tonial M, Baggio Simeoni PR, Stadler Tasca Ribeiro V, Silvestre R, de Carvalho KAT, Napimoga MH, Cesar Francisco J, Guarita-souza LC. Autologous Bone Marrow Mononuclear Cells (BMMC)-Associated Anti-Inflammatory Nanoparticles for Cardiac Repair after Myocardial Infarction. JFB 2022;13:59. [DOI: 10.3390/jfb13020059] [Reference Citation Analysis]
2 Chen F, Zhang X, Chen Y, Chai Y, Jiang X, Li H. Construction of lncRNA-miRNA-mRNA network based on ceRNA mechanism reveals the function of lncRNA in the pathogenesis of gout. J Clin Lab Anal 2022;:e24451. [PMID: 35524416 DOI: 10.1002/jcla.24451] [Reference Citation Analysis]
3 Trindade da Silva CA, Clemente-Napimoga JT, Abdalla HB, Basting RT, Napimoga MH. Peroxisome proliferator-activated receptor-gamma (PPARγ) and its immunomodulation function: current understanding and future therapeutic implications. Expert Rev Clin Pharmacol 2022. [PMID: 35481412 DOI: 10.1080/17512433.2022.2071697] [Reference Citation Analysis]
4 Khoei HA, Rahimi-Madiseh M, Dehkordi KA, Mohammadabadi MSM, Mohammadi S, Sadeghian R. Physospermum cornubienseL. alleviates nociceptive and neuropathic pain: Evidences and possible mechanisms. J Ethnopharmacol 2022;:114957. [PMID: 34995691 DOI: 10.1016/j.jep.2021.114957] [Reference Citation Analysis]
5 Santos DFS, Donahue RR, Laird DE, Oliveira MCG, Taylor BK. The PPARγ agonist pioglitazone produces a female-predominant inhibition of hyperalgesia associated with surgical incision, peripheral nerve injury, and painful diabetic neuropathy. Neuropharmacology 2021;205:108907. [PMID: 34856203 DOI: 10.1016/j.neuropharm.2021.108907] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Kumagai CM, Martinez RM, Colombo BB, Saito P, Pinto IC, Rodrigues CCA, Vale DL, Matos RLN, Bracarense APFRL, Baracat MM, Georgetti SR, Clemente-Napimoga JT, Napimoga MH, Fattori V, Verri WA Jr, Casagrande R. Topical Administration of 15-Deoxy-Δ 12,14-Prostaglandin J2 Using a Nonionic Cream: Effect on UVB-Induced Skin Oxidative, Inflammatory, and Histopathological Modifications in Mice. Mediators Inflamm 2021;2021:9330596. [PMID: 34764817 DOI: 10.1155/2021/9330596] [Reference Citation Analysis]
7 Zaninelli TH, Fattori V, Verri WA Jr. Harnessing Inflammation Resolution in Arthritis: Current Understanding of Specialized Pro-resolving Lipid Mediators' Contribution to Arthritis Physiopathology and Future Perspectives. Front Physiol 2021;12:729134. [PMID: 34539449 DOI: 10.3389/fphys.2021.729134] [Reference Citation Analysis]
8 de Azambuja G, Jorge CO, Gomes BB, Lourenço HR, Simabuco FM, Oliveira-Fusaro MCG. Regular swimming exercise prevented the acute and persistent mechanical muscle hyperalgesia by modulation of macrophages phenotypes and inflammatory cytokines via PPARγ receptors. Brain Behav Immun 2021;95:462-76. [PMID: 33964434 DOI: 10.1016/j.bbi.2021.05.002] [Reference Citation Analysis]
9 Huang R, Zhang C, Wang X, Hu H. PPARγ in Ischemia-Reperfusion Injury: Overview of the Biology and Therapy. Front Pharmacol 2021;12:600618. [PMID: 33995008 DOI: 10.3389/fphar.2021.600618] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Li X, Guo Q, Ye Z, Wang E, Zou W, Sun Z, He Z, Zhong T, Weng Y, Pan Y. PPAR γ Prevents Neuropathic Pain by Down-Regulating CX3CR1 and Attenuating M1 Activation of Microglia in the Spinal Cord of Rats Using a Sciatic Chronic Constriction Injury Model. Front Neurosci 2021;15:620525. [PMID: 33841075 DOI: 10.3389/fnins.2021.620525] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
11 Santos DFS, Melo-Aquino B, Jorge CO, Clemente-Napimoga JT, Taylor BK, Oliveira-Fusaro MCG. Prostaglandin 15d-PGJ2 targets PPARγ and opioid receptors to prevent muscle hyperalgesia in rats. Neuroreport 2021;32:238-43. [PMID: 33470759 DOI: 10.1097/WNR.0000000000001575] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Cheng Q, Wu H, Du Y. The roles of small-molecule inflammatory mediators in rheumatoid arthritis. Scand J Immunol 2021;93:e12982. [PMID: 33025632 DOI: 10.1111/sji.12982] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
13 Klück V, Liu R, Joosten LAB. The role of interleukin-1 family members in hyperuricemia and gout. Joint Bone Spine 2021;88:105092. [PMID: 33129923 DOI: 10.1016/j.jbspin.2020.105092] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
14 Napimoga MH, Dantas Formiga WD, Abdalla HB, Trindade-da-Silva CA, Venturin CM, Martinez EF, Rossaneis AC, Verri WA Jr, Clemente-Napimoga JT. Secreted Osteoclastogenic Factor of Activated T Cells (SOFAT) Is Associated With Rheumatoid Arthritis and Joint Pain: Initial Evidences of a New Pathway. Front Immunol 2020;11:1442. [PMID: 32849501 DOI: 10.3389/fimmu.2020.01442] [Reference Citation Analysis]
15 Wang B, Chen S, Qian H, Zheng Q, Chen R, Liu Y, Shi G. Role of T cells in the pathogenesis and treatment of gout. Int Immunopharmacol 2020;88:106877. [PMID: 32805695 DOI: 10.1016/j.intimp.2020.106877] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Abdalla HB, Napimoga MH, Macedo CG, Bonfante R, De Araujo D, de Mello NF, Carvalho LB, Fraceto LF, Clemente-napimoga JT. Poloxamer micellar system for intra-articular injection of 15-deoxy-Δ12,14-prostaglandin J2 with improved bioavailability and anti-inflammatory properties in the temporomandibular joint of rats. International Journal of Pharmaceutics 2020;583:119383. [DOI: 10.1016/j.ijpharm.2020.119383] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
17 Trindade-da-Silva CA, Clemente-Napimoga JT, Abdalla HB, Rosa SM, Ueira-Vieira C, Morisseau C, Verri WA Jr, Montalli VAM, Hammock BD, Napimoga MH. Soluble epoxide hydrolase inhibitor, TPPU, increases regulatory T cells pathway in an arthritis model. FASEB J 2020;34:9074-86. [PMID: 32400048 DOI: 10.1096/fj.202000415R] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
18 Wack G, Eaton P, Schmidtko A, Kallenborn-Gerhardt W. Redox regulation of soluble epoxide hydrolase does not affect pain behavior in mice. Neurosci Lett 2020;721:134798. [PMID: 32006628 DOI: 10.1016/j.neulet.2020.134798] [Reference Citation Analysis]
19 Kytikova OY, Perelman JM, Novgorodtseva TP, Denisenko YK, Kolosov VP, Antonyuk MV, Gvozdenko TA. Peroxisome Proliferator-Activated Receptors as a Therapeutic Target in Asthma. PPAR Res 2020;2020:8906968. [PMID: 32395125 DOI: 10.1155/2020/8906968] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
20 Burstein SH. The chemistry, biology and pharmacology of the cyclopentenone prostaglandins. Prostaglandins Other Lipid Mediat 2020;148:106408. [PMID: 31931079 DOI: 10.1016/j.prostaglandins.2020.106408] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
21 Peng S, Li P, Liu P, Yan H, Wang J, Lu W, Liu C, Zhou Y. Cistanches alleviates sevoflurane-induced cognitive dysfunction by regulating PPAR-γ-dependent antioxidant and anti-inflammatory in rats. J Cell Mol Med 2020;24:1345-59. [PMID: 31802591 DOI: 10.1111/jcmm.14807] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
22 Li J, Guo C, Wu J. 15-Deoxy-∆-12,14-Prostaglandin J2 (15d-PGJ2), an Endogenous Ligand of PPAR-γ: Function and Mechanism. PPAR Res 2019;2019:7242030. [PMID: 31467514 DOI: 10.1155/2019/7242030] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 8.3] [Reference Citation Analysis]
23 Wang J, Chen G, Lu L, Zou H. Sirt1 inhibits gouty arthritis via activating PPARγ. Clin Rheumatol 2019;38:3235-42. [DOI: 10.1007/s10067-019-04697-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
24 Staurengo-Ferrari L, Badaro-Garcia S, Hohmann MSN, Manchope MF, Zaninelli TH, Casagrande R, Verri WA Jr. Contribution of Nrf2 Modulation to the Mechanism of Action of Analgesic and Anti-inflammatory Drugs in Pre-clinical and Clinical Stages. Front Pharmacol 2018;9:1536. [PMID: 30687097 DOI: 10.3389/fphar.2018.01536] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 12.0] [Reference Citation Analysis]
25 Galvão I, Queiroz-Junior CM, de Oliveira VLS, Pinho V, Hirsch E, Teixeira MM. The Inhibition of Phosphoinositide-3 Kinases Induce Resolution of Inflammation in a Gout Model. Front Pharmacol 2018;9:1505. [PMID: 30666201 DOI: 10.3389/fphar.2018.01505] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]